Aratana Therapeutics, Inc. (Nasdaq: PETX) is a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats. Our mission is to successfully develop and deliver best-in-class therapeutics, provide comprehensive service to veterinarians and serve as a collaborator of choice for human and animal health companies. We believe our therapeutics are highly differentiated, resolve recognizable needs in compelling markets and have therapeutic profiles superior to the standard of care. Our FDA-approved and commercially available therapeutics include: - A prostaglandin receptor antagonist that specifically targets the EP4 receptor to target osteoarthritis pain and inflammation in dogs - A selective ghrelin receptor agonist that mimics ghrelin, the naturally-occurring “hunger hormone,” to stimulate appetite in dogs - A long-acting, local anesthetic that provides up to 72 hours post-operative pain relief following certain surgeries in dogs and cats
View Top Employees from Aratana Therapeutics Inc.Website | https://www.aratana.com |
Ticker | PETX |
Revenue | $25.6 million |
Funding | $34.5 million |
Employees | 17 (17 on RocketReach) |
Founded | 2010 |
Address | 11400 Tomahawk Creek Parkway Suite 340, Leawood, Kansas 66211, US |
Phone | (913) 353-1000 |
Fax | (913) 904-9641 |
Technologies | |
Industry | Biotechnology, Pharmaceuticals, Pharmaceutical Manufacturing, Drug Manufacturing & Research, Animal Health, Science and Engineering, Healthcare, Health Care, Veterinary Medicine, Pharmaceutical, Pet Therapeutics, Companion Animal, Veterinarian, Research And Development |
Web Rank | 2 Million |
Keywords | Entyce, Entyce For Dogs, Using Entyce With Mirtazapine, Aratana Therapeutics, Capromorelin, What To Do When My Dog Will Not Eat. I Believe She Is Constipated, Entyce Cost |
Competitors | 22nd Century Group, Inc., Parnell Veterinary Pharmaceuticals, Piedmont Pharmaceuticals, Putney, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325412 Companies, NAICS Code 325 Companies |
Looking for a particular Aratana Therapeutics Inc. employee's phone or email?
The Aratana Therapeutics Inc. annual revenue was $25.6 million in 2024.
Ernst Heinen is the Chief Development Officer of Aratana Therapeutics Inc..
17 people are employed at Aratana Therapeutics Inc..
Aratana Therapeutics Inc. is based in Leawood, Kansas.
The NAICS codes for Aratana Therapeutics Inc. are [32, 32541, 3254, 325412, 325].
The SIC codes for Aratana Therapeutics Inc. are [28, 283].